In 1972 Mr.M.V Rama Raju the chief promoter of Vasudha Pharma Chem Limited (VPCL) has started his professional carrier in South India Research Institute SIRIS, Hyderabad, India as a Manufacturing chemist. During his five years career with Siris, well acquainted with the process of Analgin, Niacinamide, Ethyl Nicotinate, Benzyl Nicotinate etc., biological products like Peptone, Pepaine and Heparin.

In 1977, he promoted Aravind Chemical Industries (ACI). Manufactured Niacin an intermediate for Niacinamide, B - complex vitamin, Isonicotinic acid-on intermediate for Isoniazid. Dr. Karanth Laboratories and Pfizer India Ltd., Bombay.

ACI also manufactured 'Thiosemicarbazide' - a drug Intermediate for Thiacaetazone and Sulphamethizole for export to European countries.

In 1990,ACI started R& D activities and consultancy services for execution of projects on turnkey basis.

The ACI has to its credit the following two molecules developed in its R & D laboratory/pilot plant:

• Phenylpropanolamine Hydrochloride
• Flutamide

In 1979, Mr. M.V Rama Raju promoted Hy-Fabs a chemical Equipment Fabrication Company.Besides manufacturing chemical equipment for captive use in his plant and also supplied chemical equipment like Reactors, Centrifuges, heat Exchangers, Leaf Filters, Tray Driers etc., to various reputed Bulk Drugs and Pharmaceutical Industries.

In 1984, Mr. M.V Rama Raju with a few business associates, has also promoted HICEL PHARMA(P) LTD. to manufacture exclusively Analgin, initially produced 100 tons and finally the plant reached 300 tons capacity with highest turnover Rs. 70 million (US $ 2.4 million). He acted as its Managing Director from its inception.

Mr. M.V. Rama Raju has finally launched broad based activities by merging the following inherent strengths of his Companies.

• R & D and production of Bulk Drugs & Intermediates.
• Chemical Equipment Designing.
• Product & Project Consultancy for Bulk Drugs.

And promoted Vasudha Pharma Chem Limited with the following objects:

• To establish a most modern US FDA oriented Bulk Drug plant to produce multi products meeting International standards.
• Strengthen R & D efforts by including more scientists and a better equipped R & D facility to develop new molecules/methods.
• Undertake manufacture of Bulk Drugs and drug intermediates based on customer requirement.
• Provide Product and project consultancy for Bulk Drug Industry and Global Customers.